SAN DIEGO (AP) 鈥� SAN DIEGO (AP) 鈥� Cardiff Oncology, Inc. (CRDF) on Tuesday reported a loss of $9.2 million in its second quarter.
On a per-share basis, the San Diego-based company said it had a loss of 14 cents.
The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 17 cents per share.
The molecular diagnostic company posted revenue of $104,000 in the period, which met Street forecasts.
_____
This story was generated by (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a at https://www.zacks.com/ap/CRDF
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
